Compare CLNN & NISN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CLNN | NISN |
|---|---|---|
| Founded | 2012 | 2005 |
| Country | United States | China |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Metal Fabrications |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 120.6M | 19.4M |
| IPO Year | N/A | 2016 |
| Metric | CLNN | NISN |
|---|---|---|
| Price | $6.76 | $3.34 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 6 | 0 |
| Target Price | ★ $32.67 | N/A |
| AVG Volume (30 Days) | ★ 315.5K | 10.6K |
| Earning Date | 11-13-2025 | 11-12-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 1.43 |
| Revenue | $214,000.00 | ★ $340,219,546.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $87.58 | N/A |
| P/E Ratio | ★ N/A | $14.83 |
| Revenue Growth | N/A | ★ 8.05 |
| 52 Week Low | $2.28 | $3.22 |
| 52 Week High | $13.50 | $9.33 |
| Indicator | CLNN | NISN |
|---|---|---|
| Relative Strength Index (RSI) | 40.52 | 38.89 |
| Support Level | $5.42 | $3.25 |
| Resistance Level | $7.03 | $3.50 |
| Average True Range (ATR) | 0.97 | 0.15 |
| MACD | -0.23 | -0.02 |
| Stochastic Oscillator | 24.91 | 19.30 |
Clene Inc is a clinical-stage pharmaceutical company pioneering the discovery, development, and commercialization of novel clean-surfaced nanotechnology (CSN) therapeutics. It is focused on the development of therapeutics for neurodegenerative diseases. It developed an electro-crystal-chemistry drug development platform that enables the production of concentrated, stable, clean-surfaced nanocrystal suspensions. It operates in one segment the development and commercialization of dietary supplements (Supplements). Products includes CNM-Au8, CNM-ZnA, CNM-AgZn17, rMetx, KHC46.
NiSun International Enterprise Development Group Co Ltd is a provider of supply chain solutions and integrated financial services. Nisun is dedicated to providing professional supply chain solutions to Chinese and foreign enterprises and financial institutions. Through its subsidiaries, it is engaged in delivering supply chain solutions, and supply chain trading services to its customers across different industries. The company also provides financial solutions to small and mid-sized enterprises within the supply chain ecosystem. Using its fintech platforms, it provides various financing options, including supply chain financing, trade financing, and receivables financing. Geographically, its operations are predominantly focused on markets within the People's Republic of China.